Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances (Q57107736)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

title

Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

intrahepatic cholangiocarcinoma

24 April 2020

main subject

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

author name string

Alphonse E Sirica

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

John D Groopman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Florin M Selaru

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Mario Strazzabosco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Andrew X Zhu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Gregory J Gores

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

language of work or name

English

0 references

publication date

25 March 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

page(s)

1803-1815

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

24 April 2020

cites work

1 reference

7 January 2021

Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma: a retrospective analysis of 156 cases in a single center

1 reference

7 January 2021

Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting

1 reference

7 January 2021

Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis

1 reference

7 January 2021

Surveillance in cholangiocellular carcinoma

1 reference

7 January 2021

Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma

1 reference

7 January 2021

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

1 reference

7 January 2021

Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States

1 reference

7 January 2021

Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise

1 reference

7 January 2021

Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014

1 reference

7 January 2021

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

1 reference

7 January 2021

The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma

1 reference

7 January 2021

The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.

1 reference

7 January 2021

The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.

1 reference

7 January 2021

Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model

1 reference

7 January 2021

Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.

1 reference

7 January 2021

Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression

1 reference

7 January 2021

A novel transforming growth factor beta-induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma.

1 reference

7 January 2021

Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma

1 reference

7 January 2021

Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats

1 reference

7 January 2021

Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.

1 reference

7 January 2021

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

1 reference

7 January 2021

Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.

1 reference

7 January 2021

Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases

1 reference

7 January 2021

Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis

1 reference

7 January 2021

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.

1 reference

7 January 2021

Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model

1 reference

7 January 2021

The biological and clinical challenge of liver cancer heterogeneity

1 reference

7 January 2021

Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes

1 reference

7 January 2021

Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma.

1 reference

7 January 2021

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

1 reference

7 January 2021

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

1 reference

7 January 2021

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient.

1 reference

7 January 2021

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.

1 reference

7 January 2021

Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma.

1 reference

7 January 2021

Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.

1 reference

7 January 2021

Single cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma.

1 reference

7 January 2021

Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping

1 reference

7 January 2021

Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma.

1 reference

7 January 2021

Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma

1 reference

7 January 2021

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

1 reference

7 January 2021

Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma

1 reference

7 January 2021

Early clinical efficacy of TAS-120, a covalently bound FGFR inhibitor, in patients with cholangiocarcinoma

1 reference

7 January 2021

Understanding the tumor immune microenvironment (TIME) for effective therapy.

1 reference

7 January 2021

Genomic spectra of biliary tract cancer.

1 reference

7 January 2021

Cholangiocarcinoma - evolving concepts and therapeutic strategies

1 reference

7 January 2021

Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30251463

12 December 2020

inferred from PubMed ID database lookup

Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30251463

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1002/HEP.30289

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30251463%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

1 reference